You have 1 free disease view remaining today. Register for more view, it is 100% free →
autosomal dominant intellectual developmental disorder 36
Description
Autosomal dominant intellectual developmental disorder 36, also known as MAND (Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome), is a rare genetic disorder that affects intellectual development and physical characteristics.
Key Features:
- Intellectual Disability: Children with MAND have mild to severe intellectual disability and developmental delay [7].
- Global Developmental Delay: Global developmental delay is a characteristic feature of this condition, indicating delays in multiple areas of development, such as speech, language, and motor skills [6].
- Poor Coordination: Individuals with MAND often have poor coordination and may not walk until age 2 or 3 [7].
- Facial Dysmorphism: Facial dysmorphism is a common feature of this condition, although the specific features can vary [1].
Genetic Basis:
- Autosomal dominant intellectual developmental disorder 36 is caused by mutations in the PPP2R1A gene on chromosome 19q13.41 [3].
- The PPP2R1A gene plays a crucial role in regulating protein phosphatase activity, which is essential for proper brain development and function [4].
Inheritance Pattern:
- Autosomal dominant disorders are inherited in an autosomal dominant pattern, meaning that only one copy of the mutated gene is necessary to cause the condition [9].
- Individuals with MAND can inherit the mutation from an affected parent or acquire it de novo (spontaneously) during reproduction [9].
It's essential to note that each individual with MAND may exhibit a unique combination of symptoms, and the severity of the condition can vary widely among affected individuals.
Additional Characteristics
- Intellectual Disability
- Facial Dysmorphism
- Global Developmental Delay
- Autosomal dominant intellectual developmental disorder 36
- Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome
- Poor Coordination
Signs and Symptoms
Based on the provided context, here are the signs and symptoms of autosomal dominant intellectual developmental disorder 36 (MRD36):
- Global developmental delay [3]
- Intellectual disability or learning problems [6]
It's worth noting that MRD36 is a rare genetic condition, and more research is needed to fully understand its characteristics. However, based on available information, it appears that individuals with MRD36 may experience delays in development and intellectual impairments.
Some common features of MRD36 include:
- Delays in motor skills development, such as sitting, standing, and walking [2]
- Abnormalities in the cardiovascular system, including aortic root aneurysm [1]
It's essential to consult with a medical professional for accurate diagnosis and treatment. They can provide more detailed information on MRD36 and its symptoms.
References: [1] - Clinical features · Abnormality of limbs. Arachnodactyly; Clinodactyly of the 5th finger · Abnormality of the cardiovascular system. Aortic root aneurysm ... [2] - Early symptoms include poor muscle tone (hypotonia) and delays in the devlopment of motor skills like sitting, standing, and walking. Speech is also affected, ... [3] - A rare genetic neurodevelopmental disorder characterized by global developmental delay (DD) and variable degrees of intellectual disability (ID) [6] - May 31, 2022 — This condition is characterized by mild to moderate intellectual disability or learning problems, unique personality characteristics, ...
Additional Symptoms
- Global developmental delay
- Intellectual disability or learning problems
- Delays in motor skills development (sitting, standing, walking)
- Abnormalities in the cardiovascular system (aortic root aneurysm)
- Hypotonia (poor muscle tone)
- Speech affected
Diagnostic Tests
Autosomal dominant intellectual developmental disorder 36 (ADIDD36) is a genetic condition characterized by below-average intellectual functioning and impairments in adaptive behavior.
Available Diagnostic Tests
Several diagnostic tests are available for ADIDD36, including:
- Clinical tests: A comprehensive evaluation of an individual's medical history, physical examination, and laboratory tests can help identify the presence of ADIDD36.
- Molecular Genetics Tests: Deletion/duplication analysis (12) is a type of molecular genetics test that can detect genetic mutations associated with ADIDD36.
- Prenatal diagnosis: If a pathogenic variant has previously been identified in a family member, prenatal diagnosis may be possible to confirm the presence of ADIDD36 in an unborn child.
Diagnostic Criteria
ADIDD36 is characterized by below-average intellectual functioning and impairments in adaptive behavior. A neurologic examination can help detect vital parameters such as birth appearance, activity, weight, grimace, pulse, and respiration scores [6].
Genetic Testing
Genetic testing for ADIDD36 may involve chromosomal microarray analysis, testing for fragile X syndrome, karyotype analysis, or metabolic testing [4]. Diagnostic exome sequencing in persons with severe intellectual disability can also be used to identify the underlying genetic cause of ADIDD36 [8].
Intellectual Disability Exome
The intellectual disability exome involves analysis of exome sequencing data in a predefined yet regularly updated set of genes associated with non-syndromic intellectual disability, including ADIDD36 [9].
References: [1] - 16 tests are available for this condition. [4] - Rationale for genetic testing · - Chromosomal microarray analysis · - Testing for fragile X syndrome · - Karyotype analysis · - Metabolic testing [6] - Vital parameters are detected such as the child's birth appearance, activity, weight, grimace, pulse, and respiration scores; moreover, a neurologic examination ... [8] - Genetic Tests for Intellectual Developmental Disorder, Autosomal Dominant 52 ... Diagnostic exome sequencing in persons with severe intellectual disability. [9] - The intellectual disability exome involves analysis of exome sequencing data in a predefined yet regularly updated set of genes associated with non-syndromic ...
Additional Diagnostic Tests
- Genetic testing
- Molecular Genetics Tests
- Clinical tests
- Prenatal diagnosis
- Intellectual Disability Exome
Treatment
Based on the provided context, it appears that there are limited resources available for drug treatment specifically targeting autosomal dominant intellectual developmental disorder 36 (MRD36). However, I can provide some general information related to the topic.
Treatment Overview
While specific treatments for MRD36 may not be well-documented, research suggests that various medications and therapies can help manage symptoms associated with intellectual developmental disorders. These may include:
- Behavioral interventions: Targeted behavioral therapies, such as applied behavior analysis (ABA), can help address behavioral challenges and improve communication skills.
- Medications for related symptoms: Certain medications may be prescribed to alleviate specific symptoms, like anxiety, attention deficit hyperactivity disorder (ADHD), or sleep disturbances, which are sometimes associated with intellectual developmental disorders.
Specific Medications
Although I couldn't find direct references to drug treatments specifically targeting MRD36, some medications have been studied for their potential benefits in managing related symptoms:
- Risperidone: As mentioned in search result 5, risperidone has been used to treat disruptive behaviors and self-injurious behaviors in children with intellectual developmental disorders.
- Other psychotropic medications: Various other medications, such as antipsychotics, mood stabilizers, or stimulants, may be prescribed off-label for specific symptoms associated with intellectual developmental disorders.
Important Considerations
It's essential to note that:
- Each individual with MRD36 is unique, and treatment plans should be tailored to their specific needs.
- Medication use should always be guided by a qualified healthcare professional, taking into account the person's medical history, current health status, and potential interactions with other medications.
References
Please consult a qualified healthcare professional for personalized guidance on managing symptoms associated with MRD36. While I couldn't find direct references to drug treatments specifically targeting this condition, research on related intellectual developmental disorders may provide some insights into potential treatment approaches.
Citations:
- [5] Risperidone is a well-documented treatment of disruptive, aggressive, and self-injurious behaviors in children with intellectual development disorder with good ...
- [13] Prevalence of autosomal dominant ID. The prevalence of ID depends on the portion of consanguineous and non-consanguineous marriages.
- [14] Drug-food and drug-drink interactions: Food and drinks can change how medicines work or worsen side effects when they are combined.
Please consult a qualified healthcare professional for personalized guidance on managing symptoms associated with MRD36.
Recommended Medications
- Behavioral interventions
- Other psychotropic medications
- Medications for related symptoms
- risperidone
- Risperidone
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Autosomal dominant intellectual developmental disorder (ADIDD) is a condition characterized by intellectual disability inherited in an autosomal dominant pattern [6]. When considering the differential diagnosis for ADIDD, several conditions should be taken into account.
- Cohen syndrome: This rare genetic disorder is marked by multi-systemic involvement, causing developmental delays, intellectual disabilities, microcephaly, and other physical features [9].
- Crouzon syndrome with acanthosis nigricans (Crouzonodermoskeletal syndrome): This condition is characterized by intellectual disability, hypogenitalism, and inheritance in an autosomal recessive pattern [8]. While it shares some similarities with ADIDD, the distinct inheritance pattern and additional physical features set it apart.
- MRD6: As a neurodevelopmental disorder, MRD6 can present with delayed psychomotor development and intellectual disability of variable severity. However, its autosomal dominant inheritance pattern is consistent with ADIDD [2].
- MAND: Children with MAND often exhibit mild to severe intellectual disability and developmental delay, which may be similar to the symptoms seen in ADIDD [1]. However, the distinct physical features and coordination issues associated with MAND set it apart from ADIDD.
- Global developmental delay (DD) and variable degrees of intellectual disability (ID): This rare genetic neurodevelopmental disorder can present with global developmental delay and varying degrees of intellectual disability. While it shares some similarities with ADIDD, the distinct inheritance pattern and additional physical features may be relevant in differential diagnosis [4].
- Chromosomal anomalies: These often result in multiple physical defects as well as mental and developmental delay. In cases where there are no clear chromosomal abnormalities, conditions like ADIDD should be considered [3].
It's essential to note that a comprehensive evaluation and diagnostic workup are necessary to accurately diagnose ADIDD and rule out other potential causes of intellectual disability.
References: [1] - Context result 1 [2] - Context result 2 [3] - Context result 3 [4] - Context result 4 [6] - Context result 6 [8] - Context result 8 [9] - Context result 9
Additional Differential Diagnoses
- Chromosomal anomalies
- MRD6
- MAND
- Crouzon syndrome with acanthosis nigricans (Crouzonodermoskeletal syndrome)
- Global developmental delay (DD) and variable degrees of intellectual disability (ID)
- Cohen syndrome
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1938
- owl#annotatedSource
- t345426
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0070066
- core#notation
- DOID:0070066
- oboInOwl#hasDbXref
- MIM:616362
- IAO_0000115
- An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the PPP2R1A gene on chromosome 19q13.41.
- rdf-schema#label
- autosomal dominant intellectual developmental disorder 36
- oboInOwl#hasExactSynonym
- MRD36
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0060307
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.